Member Info for VanVan

Gold is doing very nicely this morning. Lets hope that continues.
I thought the S.P. would have been close to 3p last Christmas. I now think it should be close to 4p this Christmas, but obviously the market has a strongly different opinion. But the market can't ignore these sorts of numbers for ever.
Very impressive increase in silver production as well. I'm now looking forward to the Quarterlies to confirm those costs which sound like they will be good, but I suspect a little higher. Surely we can't deliver $371 per oz for 2 quarters!
I think the grades will hold up. Kerim happy to use the 5% number. By Xmas I'm guessing the loan will be down to 50% as well. Just 15 months after that and we have a cash cow for 6/12 months!

Well I've been working through various things to build my understanding. The Hardman Report was very helpful indeed. Thanks for the link.
What I like so far:-
1. Scancell is the first Co. in the world to demonstrate that tumour cells are excellent targets for vaccine therapy.
2. Short listed for CRUK prestigious Grand Challenge award.
3. Worldwide recognition - patents in place
4. Has 2 novel & distinct proprietary platforms.
5. Just a small % of the $120 billion market would represent a very attractive return on investment.
6. Scancell's platforms are potentially very attractive to big Pharma and or Biotech companies.
7. Scancell's infection point estimated as fiscal 2020.
8. Has sufficient cash to progress human trials (Modi-1) and SCIB being funded by CRUK
9. Chairman said in AR & A that Modi-1 may be effective in up to 90% of patients with TNBC, up to 95% with Ovarian cancer & 100% of patients with sarcoma. If the human trials endorse this - well work it out for yourself what is likely to happen!
10. 2019 is a year when real progress should be made - short term.
11. Modi-1 Supported and endorsed by ISA Pharmaceutical & BioNTech.
12.Strategic Research collaboration with the Rheumatolgy Unit at Karolinska Institute
13. Agreement with Univ. of Nottingham to licence several novel monoclonal antibodies against tumour associated glycans
14. There don't seem to be many competitors in their direct space and Scancell seem to me to be at the leading edge. Might be wrong of course as I'm no scientist.

From an investor point of view, I'm pleased to see Institutional Investors supporting the Co. (Legal & General, Calculus, City Financial etc.) Directors have 5% skin in the game.
Oncology mark said to grow 7/10% compound to $165 billion plus by 2020.
Has cash and a good programme of news flow.
There are risks that the trials disappoint , but overall I can see the attraction here.

Nailed it. As I expected. Notwithstanding all that heavy rain.
Great in every sense. Got to be over 25000 ozs for the year.
I think they could try and state their guidance more accurately!!!

There was NO DEAL made with Turkey for the release and return of Pastor Andrew Brunson. I don’t make deals for hostages. There was, however, great appreciation on behalf of the United States, which will lead to good, perhaps great, relations between the United States & Turkey!

Kerim presenting at FINEX 18 London at 14.35 on Wednesday- ?A development case history of Salinbas gold-silver deposit?

Reuters - A U.S. pastor was flown out of Turkey on Friday after a court freed him from two years of detention, in a step that could improve U.S.-Turkish ties strained by disputes over Syria, Iran and Ankara’s planned purchase of Russian military equipment

https://www.youtube.com/watch?v=FN7uWRmADYY

Thanks moonparty.

Another helpful post crumbs.
That is what I was trying to get at.
Whilst the trial could take most of 2019, I can see positive results could be transformational for the Co. and for those struggling with this terrible ball and chain.
It would appear that long term loyal shareholders will do very well and their patience will be rewarded.
I’m slowly getting more excited!

Biggles who went on the Site visit on ADVFN
They said they had flooding for six days which did NOT interrupt production due to the stored ore. The figures Last month were exceptional if we get near them I’d be very happy. They were good because of the high g/t content and to a lesser extent the lira. The JV has built and funded the road so cost per ounce depends on how they treat that additional cost. When I was there there was nothing to indicate adverse production for the quarter MDV and KS genuinely did not have the data for the quarterlies. I cannot indicate what it’s going to be but I’d be very happy with around 6000 ounces at cost sub $600 per ounce. I’m really waiting for elaboration of interim rns on venture to unlock shareholder value. Six reasonable quarters and debt free $6m p.a cash to do what they do best - EXPLORATION

Hi Ray , for some reason I can’t find the Hardman report you refer to. Sorry to be a nuisance but can you help me locate it? Thanks

Thanks everyone. It does sound amazing Chester.
It is perhaps amazing that if the results so far are so confirmationary, even if only on mice, that more isn’t being made of this potential transformational break through in the press (media) and the industry generally.
Also that pte investors haven’t seen the potential or for that matter Institutional Investors. I know we have some - Calculas , Legal & General etc but at this price you would expect perhaps to see more, plus director buying of course.
And finally my point about the Co. being vulnerable to a take-over offer long before it has been able to create proper value for its loyal, long standing investors.
But then I guess the Directors are as much focussed on what they can bring to society as they are about maxisimising the Co’s value.
If there are any other knowledge investors on this thread please do add to my slim understanding .
Thanks again.

But we should get the Preliminary Production Results fairly soon.
The last ones were on 11th July.

Hope that helps - yes it does and i’m very greatful to you for sharing your informed comments.
I’m assuming that a Pharmaceutical Co. will buy it and run with it once the testing/trialing/proving period provides sufficient endorsement of fact. If it is already proven, wouldn’t you expect a Pharma to want to buy sooner than later.
But you say there are many hundreds in this space so I assume they are spoilt for choice.
That seems a shame as it must dissipate progress. Surely they could proceed quicker and with better funding if the joined up?
Could you tell me who are the main competitors please?
Thanks again.

I’m new and a greenhorn. Can someone help me understand a basic question please?
There are obviously a lot of very well informed, long term investors here.
I’m very encouraged by what I have read and listened too from the Co’s website, and the passion of Prof Lindy etc. who presents very well. But how unique is this new cure for cancers? Are there other Co’s. in this space? If there are, what makes us unique or the one to invest in?
Looking to the future and break through commercialisation , what is the outline process and rough timescales?
At this point in time how would someone describe the significance of this work on delivering a cancer cure, or is it only for a limited number of cancers?
If this is asking too much where should I attempt to answer these questions please?
Many thanks if someone can help.

Fair comment John

I cant see any reason but has our fall today been influenced by Wolf?

John with respect I can't see one hint in any of the recent RNS's that we should be expecting worse performance, let alone your view that they will be "materially worst".
We are told that they are on plan to meet guidance but as we now from Kerim's highly conservative style, that means he will exceed guidance. Given production in Q1 was 4866 ozs & Q2 was 7171 ozs (12037 ozs for 6 months) 20,000 ozs for the year looks easily achieved. I suspect it with be closer to 23,000 ozs.
I can understand you wanting to exercise caution, but I can't see much point in us introducing emotive terms like significantly worst, unless we have tangible grounds for doing so. Please tell me if I have missed something that Kerim or Michael have said.

Hi John
Not sure where you get this materially worst from?
Did I miss something?
I see some gold shares are up today on strengthening gold price.

Should have said - in my opinion- DYOR